Member Info for Fruitsnveg

BJW has a huge sofa, I just know it.

It appears from my scouting that this event is watertight, only delegates from the press (via submission of press passes), delegates (with registration docs), etc, can register and attend. I have read one or 2 incredibl lazy deramping articles already online, so as sure as day follows night, I expect there to be a de-ramping exercise over the next few days, probably along the lines of 'xyz was reported at the conference'. DYOR - as you'll see, the sessions and that discussed are watertight. Unless the company put out another RNS divulging news, then that would be to be believed.
GLA.

Irrelevant Doc83. Unless you think positive data (confirmation hat SNG001 works on 3 variants) is somehow going to drive the US SP down? If you weren't willing to stump up $400 - 500 to watch the presentation, I doubt other punters in the US were either. II's will be well ahead of the game, they don't need to watch these presentations.

Last small top up from me. GLA.

Thank you Ndn17, found it. I note there was a predominantly Univ. of Southampton session on 4th too. Great things coming out of Univ. Southampton on respiratory front, they deserve it.
In my mind, they signed up for the conference (and submitted their variants data) before 30th Sept, so Monk's address will have been written pre-Omni and pre-Sprinter end. It will be interesting to know what will be said.

You mean in the conference Ndn17?

I think you are right Saint, at least, I don't recall Gamma being referenced previously?

Abstract: 269 is mentioned in the RNS.
On the conference website the 'End of abstract submission' is given as 30th sept 2021.
Submission of an abstract acknowledges your acceptance for the abstract to be published in the official Congress publications. The presenting author is required to ensure that all co-authors are aware of the content of the abstract and agree to its submission, before submitting the abstract.

So, IMO this RNS (and conference) has been in the offing for some time. The BOD didn't just decide to present at this conference yesterday, it will have been diarised some months ago give the submission date (30th Sept). So I wouldn't worry about it - all good and expected progress getting the SNG001 story out there to industry professionals and beyond.

IMO, volatility in the markets. Big sell off of crypto over the weekend has created new opportunities for some, then there's still questions over inflation, ECB/rates, economic implications of Omni etc. Monday morning eh.

Tyla, I can't remember Tony's last post, can you elaborate?
Thanks

So, very reduced competition you're saying from the Merck pill, TommyD_19.
That's great news. Thanks for posting.

Golly!
If this mornings wind direction is anything to go by, Monday looks to be the targeted deramping day. Always good to know in advance, most helpful of them to provide a regular signal.
Back to the article and it’s bizarre overuse of the word ‘asset’. All I can think is Matt Damon would be very annoyed.

Excellent.

Actually, a year and a day ago....

"Translating biological science into human disease and then improving human health... has been a rewarding journey." Congratulations to Professor Stephen Holgate on his Knighthood for medical research in the Queen’s Birthday Honours List. 1st December 2020.

Let's raise a virtual glass to SSH, and all the hard-working scientists who spend a lifetime persisting. Without them none of us would be here enjoying arguing with each other day after day. Jokes aside, they are the best.

Cheers SSH ~ Clinky clinky.

plus this piece

South Africa’s health body sees threefold higher risk of reinfection
The new Omicron variant of the coronavirus poses a threefold higher risk of reinfection than the currently dominant Delta variant and the Beta strain, a group of South African health bodies said. The South African Centre for Epidemiological Modelling and Analysis along with National Institute of Communicable Diseases said latest findings “provide epidemiological evidence for Omicron’s ability to evade immunity from prior infection”.
Their statement was issued after a group of South African health organisations published a paper on medrxiv.org as a pre-print, meaning the work was not yet certified by peer review.

https://www.aljazeera.com/news/2021/12/2/wrapup-1-first-omicron-case-in-u-s-adds-to-global-alarm-over-virus-variant

"Depending on certain factors I might even give some advanced warning and an explanation as to why the volatility will come (but I will decide nearer the time)"

AndyB4 , why can't you lay your stall out now and give your explanation?

Agree Skippy. No worries.

Thank you Skippy. Yes ridiculously miniscule number. As you probably know I am not anti-vax, The reason I posted it is because of the implications for AZ Vax production. They may have to go back to the drawing board (a little) now before wheeling out more. Up until now this clot issue was suspected but not proven, now they know what causes it. AZ will need to do some work.

https://www.bbc.co.uk/news/health-59418123

Christmas parties. There they go.

https://www.reuters.com/world/europe/norways-third-omicron-case-detected-after-company-christmas-party-2021-12-02/